A paradigm shift is emerging in the management of asthma, where the aim is not only asthma control but also remission. It has been shown that this ambitious goal can be achieved with highly effective anti-inflammatory drugs that are available today. The determination of type 2 markers is of great importance in this therapy concept. The aim is to implement the individually appropriate therapy as early as possible in the course of the disease.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Case report: bronchobiliary fistula
Disguised as pneumonia
- Rehospitalization risk for cardiopulmonary diseases
Transition to the outpatient setting is crucial
- Telemonitoring
Home earlier: sensory T-shirt monitors vital functions
- Ginkgo biloba for mild dementia: new meta-analysis
Improvements in several domains relevant to everyday life
- From symptom to diagnosis
Dyspnea – Lung metastases
- Potential biomarkers for diagnostics, prognosis and therapy
Male infertility
- Artesunate in uro-oncology
Integrin modulation for the control of metastases in cisplatin-resistant bladder cancer
- Long-term study with dementia patients